Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic-mediated Improvements in Vigilance: Mechanisms of Action of Clarithromycin in Hypersomnia Syndromes

NCT04026958 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT04026958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04026958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic-mediated Improvements in Vigilance: Mechanisms of Action of Clarithromycin in Hypersomnia Syndromes
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Completed
Start date
September 4, 2019
Completion date
June 18, 2025
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic hypersomnia, narcolepsy with cataplexy, narcolepsy without cataplexy